quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:08·813d
SECFiling
Navidea Biopharmaceuticals Inc. logo

SEC Form EFFECT filed by Navidea Biopharmaceuticals Inc.

NAVB· Navidea Biopharmaceuticals Inc.
Health Care
Original source

Companies

  • NAVB
    Navidea Biopharmaceuticals Inc.
    Health Care

Related

  • PR197d
    Navidea Biopharmaceuticals, Inc. Files for Bankruptcy
  • PR337d
    Navidea Biopharmaceuticals, Inc. Announces Extension of Authority to Implement a Reverse Stock Split
  • PR388d
    Navidea Biopharmaceuticals Announces the Extension of Plan Designed to Protect NOLs and Other Tax Assets
  • PR659d
    Navidea Biopharmaceuticals, Inc. Announces Results of Exploratory Analysis Completed on July 2, 2024
  • PR672d
    Navidea Biopharmaceuticals, Inc. announces special meeting of stockholders to be held July 8, 2024
  • 13D/G808d
    SEC Form SC 13D/A filed by Navidea Biopharmaceuticals Inc. (Amendment)
  • SEC813d
    SEC Form EFFECT filed by Navidea Biopharmaceuticals Inc.
  • SEC813d
    SEC Form EFFECT filed by Navidea Biopharmaceuticals Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022